Insider · CIK 0001733915

Giordano Michael F

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001733915

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-03	RAPTRAPT Therapeutics, Inc.U Disposition from Tender	Director	UDisposition from Tender	−4,956 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−824 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−799 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−938 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−938 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−402 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,063 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,618 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,561 sh	—	—	0
2026-03-03	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.2K sh	—	—	0
2026-01-30	RAPTRAPT Therapeutics, Inc.A Award	Director	AAward	+4,956 sh	—	—	4,956
2025-05-29	RAPTRAPT Therapeutics, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+258K sh	—	—	257,832
2024-05-22	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+36.5K sh	—	—	36,490
2023-05-24	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.9K sh	—	—	12,940
2022-08-12	Epizyme, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,060 sh	—	—	8,994
2022-08-12	Epizyme, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−8,994 sh	—	—	0
2022-05-25	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500
2022-05-17	Epizyme, Inc.A Award	Director	AAward	+8,994 sh	—	—	17,054
2022-05-17	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+41K sh	—	—	41,006
2022-03-31	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,213 sh	$16.80	+$54K	3,213
2021-06-11	Epizyme, Inc.A Award	Director	AAward	+8,060 sh	—	—	8,060
2021-06-11	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40.6K sh	—	—	40,559
2021-05-28	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-06-25	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.1K sh	$6.18	+$62.2K	10,069
2020-06-25	RAPTRAPT Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+8,944 sh	$12.00	+$107K	8,944
2020-06-25	RAPTRAPT Therapeutics, Inc.S Sale	Director	SSale	−19K sh	$33.37	−$634K	0
2020-06-25	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.1K sh	—	—	6,597
2020-06-25	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,944 sh	—	—	6,390
2020-06-18	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2020-05-29	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+14K sh	—	—	14,013
2019-10-30	RAPTRAPT Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.3K sh	—	—	15,334
2019-05-31	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.6K sh	—	—	17,633
2018-03-08	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Mar 54
Giordano Michael F0001733915-26-000003
SEC(opens sec.gov)
Feb 24
Giordano Michael F0001733915-26-000002
SEC(opens sec.gov)
Jun 24
Giordano Michael F0001415889-25-015230
SEC(opens sec.gov)
May 234
Giordano Michael F0001415889-24-014374
SEC(opens sec.gov)
May 254
Giordano Michael F0001209191-23-032284
SEC(opens sec.gov)
Aug 164
Giordano Michael F0000899243-22-028875
SEC(opens sec.gov)
May 264
Giordano Michael F0001209191-22-032313
SEC(opens sec.gov)
May 194
Giordano Michael F0000899243-22-018838
SEC(opens sec.gov)
Apr 44
Giordano Michael F0001209191-22-022604
SEC(opens sec.gov)

Companies

Address

C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE

SOUTH SAN FRANCISCO, CA, 94080